Fintel reports that on January 10, 2025, Piper Sandler initiated coverage of ResMed (NYSE:RMD) with a Neutral recommendation.

Fintel reports that on January 10, 2025, Piper Sandler upgraded their outlook for NIKE (NYSE:NKE) from Neutral to Overweight.

Valero Energy and Par Pacific stocks upgraded by Piper Sandler, while Phillips 66 downgraded due to low leverage and capital ...

Piper Sandler analyst Ryan Todd upgraded Valero (VLO) to Overweight from Neutral with a price target of $149, up from $123. The company ...

Nike CEO Elliott Hill has an "intensified urgency to clean up the marketplace" so expect a "visible recovery story," analyst ...